These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32769142)

  • 21. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.
    Taranger J; Trollfors B; Bergfors E; Knutsson N; Lagergård T; Schneerson R; Robbins JB
    Pediatrics; 2001 Dec; 108(6):E115. PubMed ID: 11731642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acellular pertussis vaccines and pertussis resurgence: revise or replace?
    Ausiello CM; Cassone A
    mBio; 2014 Jun; 5(3):e01339-14. PubMed ID: 24917600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Mucosal Immunity in Pertussis.
    Solans L; Locht C
    Front Immunol; 2018; 9():3068. PubMed ID: 30692990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of respiratory model employing conventional NIH mice to access the immunity induced by cellular and acellular pertussis vaccines.
    Dias AA; Boller MA; Werneck LM; Hirata Junior R; Mattos-Guaraldi AL
    Mem Inst Oswaldo Cruz; 2006 Nov; 101(7):749-54. PubMed ID: 17160282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies recognizing protective pertussis toxin epitopes are preferentially elicited by natural infection versus acellular immunization.
    Sutherland JN; Chang C; Yoder SM; Rock MT; Maynard JA
    Clin Vaccine Immunol; 2011 Jun; 18(6):954-62. PubMed ID: 21508166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell immune responses to Bordetella pertussis infection and vaccination.
    Fedele G; Cassone A; Ausiello CM
    Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26242279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of Toll-like receptor-4 in pertussis vaccine-induced immunity.
    Banus S; Stenger RM; Gremmer ER; Dormans JA; Mooi FR; Kimman TG; Vandebriel RJ
    BMC Immunol; 2008 May; 9():21. PubMed ID: 18498620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. National study of infants hospitalized with pertussis in the acellular vaccine era.
    Elliott E; McIntyre P; Ridley G; Morris A; Massie J; McEniery J; Knight G
    Pediatr Infect Dis J; 2004 Mar; 23(3):246-52. PubMed ID: 15014301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with whole cell but not acellular pertussis vaccines primes CD4 T
    Wilk MM; Borkner L; Misiak A; Curham L; Allen AC; Mills KHG
    Emerg Microbes Infect; 2019; 8(1):169-185. PubMed ID: 30866771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of pertussis: An unresolved problem.
    Esposito S; Principi N
    Hum Vaccin Immunother; 2018; 14(10):2452-2459. PubMed ID: 29856680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against
    Zurita ME; Wilk MM; Carriquiriborde F; Bartel E; Moreno G; Misiak A; Mills KHG; Hozbor D
    Front Cell Infect Microbiol; 2019; 9():125. PubMed ID: 31106160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model.
    Denoël P; Godfroid F; Guiso N; Hallander H; Poolman J
    Vaccine; 2005 Nov; 23(46-47):5333-41. PubMed ID: 16054273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serological correlates of immunity to Bordetella pertussis.
    Hewlett EL; Halperin SA
    Vaccine; 1998 Dec; 16(20):1899-900. PubMed ID: 9796040
    [No Abstract]   [Full Text] [Related]  

  • 34. Pertussis control: time for something new?
    Clark TA; Messonnier NE; Hadler SC
    Trends Microbiol; 2012 May; 20(5):211-3. PubMed ID: 22494804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice.
    Boehm DT; Hall JM; Wong TY; DiVenere AM; Sen-Kilic E; Bevere JR; Bradford SD; Blackwood CB; Elkins CM; DeRoos KA; Gray MC; Cooper CG; Varney ME; Maynard JA; Hewlett EL; Barbier M; Damron FH
    Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30012638
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of evidence supporting a role of IFN-β and TGF-β in differential polarization of Bordetella pertussis specific-T cell responses.
    da Silva Antunes R; Quiambao LG; Soldevila F; Sutherland A; Peters B; Sette A
    Cytokine; 2021 Jan; 137():155313. PubMed ID: 33002739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro.
    Queenan AM; Dowling DJ; Cheng WK; Faé K; Fernandez J; Flynn PJ; Joshi S; Brightman SE; Ramirez J; Serroyen J; Wiertsema S; Fortanier A; van den Dobbelsteen G; Levy O; Poolman J
    Vaccine; 2019 Jan; 37(1):80-89. PubMed ID: 30478007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1.
    Feunou PF; Kammoun H; Debrie AS; Mielcarek N; Locht C
    Vaccine; 2010 Oct; 28(43):7047-53. PubMed ID: 20708998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.
    Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK
    Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pertussis in the Era of New Strains of Bordetella pertussis.
    Souder E; Long SS
    Infect Dis Clin North Am; 2015 Dec; 29(4):699-713. PubMed ID: 26337739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.